5-Methyl-3-butyltetrahydropyran-4-yl acetate
Common Name: |
5-Methyl-3-butyltetrahydropyran-4-yl acetate |
IUPAC Name: |
(3-butyl-5-methyloxan-4-yl) acetate |
Molecular Formula: |
C12H22O3 |
SMILES: |
CCCCC1COCC(C1OC(=O)C)C |
Inchi: |
1S/C12H22O3/c1-4-5-6-11-8-14-7-9(2)12(11)15-10(3)13/h9,11-12H,4-8H2,1-3H3 |
Inchi Key: |
XWNKVSFNBVIKJB-UHFFFAOYSA-N |
Cas No: |
38285-49-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
214.30 |
Mass (g/mol) |
214.157 |
Molar Refractivity |
60.05 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
271.00 to 272.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.006 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.92 |
LogP |
2.391 |
iLOGP |
2.94 |
XLOGP3 |
2.84 |
WLOGP |
2.39 |
MLOGP |
1.88 |
ESOL Log S |
-2.63 |
ESOL Solubility (mg/ml) |
0.505 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.24 |
Ali Solubility (mg/ml) |
0.12 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.39 |
Silicos-IT Solubility (mg/ml) |
0.88 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.59 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.787 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.851 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |